← Back to Clinical Trials
Recruiting NCT07667985

NCT07667985 Cognitive Reserve and Post-Fatigue Recovery in Older Adults

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07667985
Status Recruiting
Phase
Sponsor Uşak University
Condition Cognitive Reserve
Study Type OBSERVATIONAL
Enrollment 400 participants
Start Date 2026-06-20
Primary Completion 2026-09-21

Eligibility & Interventions

Sex All sexes
Min Age 65 Years
Max Age 90 Years
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 400 participants in total. It began in 2026-06-20 with a primary completion date of 2026-09-21.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

As people grow older, it is common to experience a drop in physical stamina and memory functions. This can make recovering from daily physical and mental fatigue more difficult, which directly impacts an individual's independent daily life and overall quality of life. "Cognitive reserve" is a term that describes the brain's built-in resilience. Built over a lifetime through education, work, and social activities, a higher cognitive reserve acts like a buffer, helping the brain adapt to stress and aging. While research shows that a high cognitive reserve protects against conditions like dementia, we still do not fully understand how it helps older adults bounce back from normal, everyday physical and mental exhaustion. The goal of this study is to investigate how cognitive reserve levels influence how individuals aged 65 and older perceive their recovery after experiencing physical and mental fatigue. What the Study Involves The researchers will evaluate participants aged 65 and older to measure their baseline cognitive reserve levels. The study will look closely at how these levels affect the participants': Ability to cope with daily physical and mental fatigue. Need for rest and rest patterns. Time and ability to return to normal daily activities. Overall perception of their mental and physical recovery. Expected Outcome By understanding this relationship, the study aims to fill a gap in medical literature and help healthcare providers design better, more personalized rehabilitation and lifestyle support programs to improve the quality of life for older adults.

Eligibility Criteria

Inclusion Criteria: * being 65 years of age or older, * not having any neurological, psychiatric, or systemic disease that would affect one's mental state, and not using any medication for these conditions. Exclusion Criteria: * Being younger than 65 years old, * having an illness or taking medication that affects mental health, or being * unable to complete the questionnaires.

Contact & Investigator

Central Contact

Elif Tuncay, PhD

✉ elif.tuncay@usak.edu.tr

📞 +90 276 221 2121 Extension: 30

Principal Investigator

Elif Tuncay, PhD

PRINCIPAL INVESTIGATOR

Uşak University

Frequently Asked Questions

Who can join the NCT07667985 clinical trial?

This trial is open to participants of all sexes, aged 65 Years or older, up to 90 Years, studying Cognitive Reserve. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07667985 currently recruiting?

Yes, NCT07667985 is actively recruiting participants. Contact the research team at elif.tuncay@usak.edu.tr for enrollment information.

Where is the NCT07667985 trial being conducted?

This trial is being conducted at Uşak, Turkey (Türkiye).

Who is sponsoring the NCT07667985 clinical trial?

NCT07667985 is sponsored by Uşak University. The principal investigator is Elif Tuncay, PhD at Uşak University. The trial plans to enroll 400 participants.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology